Dual ROS modulation by MnO<sub>2</sub>-integrated collagen hydrogel enhances hiPSC-derived endothelial progenitor cell therapy for critical limb ischemia. [PDF]
Zhang Z +6 more
europepmc +1 more source
Racial and Ethnic Disparities in Treatment of Critical Limb Ischemia: A National Perspective. [PDF]
Wahood W +4 more
europepmc +1 more source
ABSTRACT Aims To compare lower extremity amputation (LEA) risk in adults with Type 2 diabetes and diabetic foot ulcer (DFU) treated with glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) versus other glucose‐lowering therapy, and to test whether coded peripheral arterial disease (PAD) modifies this association and replicates across comparator ...
Hani Robinson +8 more
wiley +1 more source
Sarcopenia as a Prognostic Factor for Critical Limb Ischemia: A Prospective Cohort Study. [PDF]
Luque-Linero P +5 more
europepmc +1 more source
Co-Delivery of Bioengineered Exosomes and Oxygen for Treating Critical Limb Ischemia in Diabetic Mice. [PDF]
Zhong T, Gao N, Guan Y, Liu Z, Guan J.
europepmc +1 more source
The Effects of Stroke on Oral Function and Oral Health: A Qualitative Study
ABSTRACT Introduction Stroke is the leading cause of adult disability in Aotearoa New Zealand, often resulting in a range of physical and cognitive impairments. The impacts of stroke on oral function and oral health are not well understood from the survivors' perspective, yet the latter are crucial for overall wellbeing. This qualitative study explored
Esther Cheong +4 more
wiley +1 more source
Adipose-derived dual cell therapy enhances arteriogenesis and limb preservation through vascular integration in critical limb ischemia. [PDF]
Kim DY +7 more
europepmc +1 more source
Skeletal Muscle Bioenergetics in Critical Limb Ischemia and Diabetes. [PDF]
Rontoyanni VG +13 more
europepmc +1 more source
Postoperative Treatment of Critical Limb Ischemia [PDF]
Gokalp, O. +4 more
openaire +2 more sources
ABSTRACT Introduction In patients with ischemic cardiomyopathy (ICM), recurrent VF may be treated with catheter ablation by targeting triggering premature ventricular complexes (PVCs) and/or ventricular scar homogenization. Data on optimal ablation strategies in patients with non‐ischemic cardiomyopathy (NICM) remain limited.
Kenji Hashimoto +2 more
wiley +1 more source

